Toggle navigation
Home
Search
Services
Blog
Contact
About
Human Neurons in Vitro - Characterization of Receptors
Sah, Dinah W.
Signal Pharmaceuticals, LLC, San Diego, CA, United States
Search 3 grants from Dinah Sah
Search grants from Signal Pharmaceuticals, LLC
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Melanoma suppressing functions of carcinoma oncogene FOXQ1
Global Cardiovascular Disease Policy Model for Screening Prevention and Treatment
Morphogenesis of bacteriophage phi29
Targeting of Agents to Normal and Malignant Hepatocytes
U.S./Yugoslav Workshop on Protection of Historic Structures and Town Centers in Seismic Regions: Lessons from Montenegro
Recently added grants:
Principles of presynaptic networks for single layer 2/3 neurons in ferret visual cortex
APBS: Nanoscale Biomolecular Electrostatics Software
Statistical Methods for Ultrahigh-dimensional Biomedical Data
Molecular mechanisms of chromosome organization and recombination control by the meiotic chromosome axis
Molecular mechanisms that match lysosome function to cellular demand
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Small Business Technology Transfer (STTR) Grants - Phase II (R42)
Project #
2R42AG012576-02
Application #
2054257
Study Section
Special Emphasis Panel (ZRG2-BPO (01))
Project Start
1994-09-08
Project End
1998-02-28
Budget Start
1996-08-15
Budget End
1997-02-28
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Signal Pharmaceuticals, LLC
Department
Type
DUNS #
City
San Diego
State
CA
Country
United States
Zip Code
92121
Related projects
NIH 1997
R42 AG
Human Neurons in Vitro - Characterization of Receptors
Sah, Dinah W. / Signal Pharmaceuticals, LLC
NIH 1996
R42 AG
Human Neurons in Vitro - Characterization of Receptors
Sah, Dinah W. / Signal Pharmaceuticals, LLC
Comments
Be the first to comment on this grant